Objective To summarize the nursing experience of individualized anticoagulation therapy for one patient undergoing ischemia-free liver transplantation (IFLT) combined with pancreatic islet transplantation. Methods Key postoperative nursing interventions for the patient undergoing IFLT-islet transplantation in September 2023 included: (1) dynamic monitoring of coagulation profiles for guiding precise anticoagulation therapy to prevent portal vein thrombosis (PVT), hepatic artery thrombosis (HAT), and hemorrhagic complications; (2)identification of high-risk factors combined with targeted interventions to mitigate deep vein thrombosis (DVT) risk. Results Through these measures, the patient achieved full functional recovery, and discharged on 17 days after surgery, without thrombotic or hemorrhagic events during hospitalization. During 1-year follow-up, the patient demonstrated sustained graft viability. Conclusion Nursing care for individualized anticoagulation protocol is critical for preventing vascular complications for IFLT-islet transplantation recipients, effectively promoting graft success and supporting patient recovery.
Key words
ischemia-free liver transplantation /
pancreatic islet transplantation /
anticoagulation therapy /
nursing
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 王芳菲,贺强.2023年中国肝移植临床研究年度盘点[J].器官移植,2024,15(3):377-382.DOI:10.3969/j.issn.1674-7445.2024063.
[2] 中华医学会器官移植学分会.胰岛移植临床技术操作规范(2019版)[J].器官移植, 2019, 10(6):621-627.
[3] Guo ZY, Zhao Q, Huang SZ, et al.Ischaemia-free liver transplantation in humans: a first-in-human trial[J]. The Lancet Regional Health - Western Pacific,2021,16:100260.DOI:10.1016/j.lanwpc.2021.16:100260.
[4] Zhao Q.The First Case of Intraportal Islet Implantation During Liver Machine Perfusion Allowing Simultaneous Islet-liver Transplantation in a Human - A New and Safe Treatment for End-stage Liver Disease Combined With Diabetes Mellitus[J]. Annals of Surgery, 2025, 281(2):177-184. DOI:10.1097/SLA.0000000000006526.
[5] 杨玉伟,张婷,李万里,等.胰岛移植即刻经血液介导的炎症反应应对策略[J].器官移植,2023,14(3):352-357.DOI:10.3969/j.issn.1674-7445.2023.03.005.
[6] 沈鸣雁,鲁剑芳,金亚仙,等.1例肝移植术后门静脉血栓形成继发肝衰竭患者的护理[J].中华护理杂志, 2020, 55(12):1855-1858.DOI:10.3761/j.issn.0254-1769.2020.12.017.
[7] 崔恒,傅巧美,周利平,等.终末期肝病患者接受反位肝脏供体移植手术的护理[J].中华护理杂志, 2019, 54(11):4.DOI:10.3761/j.issn.0254-1769.2019.11.025.
[8] 赵玉沛. 曾宪九胰腺病学[M].北京:人民卫生出版社,2018.
[9] Feltracco P, Barbieri S,Cillo U,et al. Perioperative thrombotic complications in liver transplantation[J]. World J Gastroenterol, 2015, 21(26):8004-8013. DO1:10.3748/wjg.v21.i26. 8004.
[10] Craig EV, Heller MT.Complications of liver transplant[J]. Abdom Radiol, 2021,46(1):43-67. DOI:10.1007/s00261-019-02340-5.
[11] 中华医学会器官移植学分会围手术期管理学组.成人肝移植受者围术期凝血功能管理专家共识(2021版)[J].实用器官移植电子杂志, 2021,9(2):89-94.DOI:10.3969/j.issn.2095-5332.2021.02.001.
[12] 杨润,邓羽霄,皋源,.成人原位肝移植围术期凝血功能异常与抗凝治疗现状[J].肝胆外科杂志,2020(5):396-400.
[13] 胡伟,康权,张明满.儿童肝移植术后发生早期肝动脉血栓的影响因素分析[J].中华消化外科杂志, 2020, 19(12):7.DOI:10.3760/cma.j.cn115610-20201202-00750.
[14] 杨泓钊,梁秋实,杨俭,等.肝移植术后早期血栓风险及预防性抗凝研究进展[J].中华器官移植杂志,2023,44(1):53-61.DOI:10.3760/cma.j.cn421203-20220727-00184.
[15] 中国超声医学工程学会浅表器官及外周血管超声专业委员会,国家卫健委脑卒中防治工程专家委员会血管超声专业委员会,中国超声医学工程学会颅脑及颈部血管超声专业委员会.腹部及外周静脉血管超声若干临床常见问题专家共识[J].中国超声医学杂志, 2020, 36(11):7-14.DOI:10.3969/j.issn.1002-0101.2020.11.001.
[16] 中国健康促进基金会血栓与血管专项基金专家委员会. 静脉血栓栓塞症机械预防中国专家共识[J].中华医学杂志, 2020, 100(7):484-492.DOI:10.3760/cma.j.issn.0376-2491.2020.07.002.
PDF(551 KB)
